Traz — Entidade

videocafe.crooksandliars.com·há cerca de 2 horas

Alcatraz Opens!

I had no idea Al Capone and Machine Gun Kelly made their prison homes on the Rock. Britannica: On this day in 1934, Alcatraz welcomed its first civilian prisoners, a group of 14 from the federal p

cincodias.elpais.com·há 3 dias

Pascal Soriot, el ‘sir’ que pasó de la ‘banlieue’ a liderar AstraZeneca

El director ejecutivo de la segunda empresa con mayor valoración en Bolsa de Reino Unido vuelve a la palestra por una ya desmentida posible fusión con BMS

biobiochile.cl·há 6 dias

Contralora Pérez expone graves falencias en ingreso de niños migrantes: no fueron solo 64 casos

La contralora Dorothy Pérez expuso ante la comisión investigadora una serie de irregularidades detectadas por la Contraloría en el ingreso de niños migrantes al país. Entre ellas, la falta de coordina

theguardian.com·há 6 dias

Soriot should explain the curious case of AstraZeneca’s non-deal

AstraZeneca’s rumoured takeover of Bristol Myers Squibb already looked weird, and was met with a lack of enthusiasm by shareholdersAstraZeneca falls to third-largest UK company amid US merger talksHol

moneytimes.com.br·há 8 dias

Vem aí nova gigante farmacêutica? AstraZeneca negocia fusão com Bristol Myers Squibb; ações reagem

O Financial Times noticiou, e a agência de notícias Reuters confirmou nesta segunda-feira (3) que houve conversas preliminares entre a anglo-sueca AstraZeneca e a norte-americana Bristol Myers Squibb

theguardian.com·há 8 dias

AstraZeneca should stick to its winning formula. It doesn’t need a $400bn US mega-merger

The Anglo-Swedish drugmaker’s flirtation with a grand combo with US group Bristol Myers Squibb is baffling• AstraZeneca shares fall 8.9% over merger talks with US cancer drug firmSir Pascal Soriot, ch

theguardian.com·há 9 dias

AstraZeneca shares fall 8.9% over merger talks with US cancer drug firm

Proposed $400bn tie-up with Bristol Myers Squibb would create world’s fourth-largest drugmaker but analysts question rationale More than £17bn was wiped off the value of Britain’s biggest drugmaker, A

braziljournal.com·há 9 dias

AstraZeneca negocia a compra da Bristol-Myers; mercado vê contraindicações

A farmacêutica AstraZeneca está negociando a compra de sua concorrente americana Bristol-Myers Squibb (BMS), reportou o Financial Times. Os termos e a probabilidade do negócio ocorrer não foram revela